SEC Form 4 · accession 0000816956-26-000096
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Gallagher
Officer — Executive Vice President & CFO
Period of report
Jul 15, 2026
Accepted (ET)
Jul 17, 2026 · 3:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000816956
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RSUs (Restricted Stock Units)F1 | $0.00 | Jul 15, 2026 | A | 35,054 | A | — | Jul 15, 2036 | Common Stock | 35,054 | 35,054 | D |
| RSUs (Restricted Stock Units)F1 | $0.00 | Jul 15, 2026 | A | 26,875 | A | — | Jul 15, 2036 | Common Stock | 26,875 | 61,929 | D |
| Options To Purchase Common StockF2 | $42.79 | Jul 15, 2026 | A | 30,536 | A | — | Jul 15, 2036 | Common Stock | 30,536 | 30,536 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
- F2The stock options were granted under CONMED Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.